Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib Era

PURPOSE: Systemic chemotherapy is the only option for patients with unresectable/metastatic hepatocellular carcinoma (HCC) who are not candidates for local/regional treatment. However, the response to such treatment and survival are poor, especially in hepatitis B virus (HBV) endemic areas. The aim...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kim, Nae Yu, Sun, Jong Mu, Kim, Yu-Jung, Lee, Keun-Wook, Kim, Jee Hyun, Bang, Soo-Mee, Kim, Jin-Wook, Jeong, Sook-Hyang, Lee, Jong Seok
Format: Artigo
Idioma:Inglês
Publicat: Korean Cancer Association 2010
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3021739/
https://ncbi.nlm.nih.gov/pubmed/21253322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2010.42.4.203
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars